Vision-Guided Serialization Systems Displace Legacy Unmarked Lines
Pharmaceutical manufacturers facing tightening anti-counterfeiting mandates are increasingly specifying vision-guided serialization packing systems that combine optical code verification with unique identifier printing, rather than the legacy unmarked blister lines that dominated the category when traceability standards were less stringent in prior decades. This shift commands meaningfully higher equipment investment than conventional unmarked lines given the vision processing and code verification requirements involved. Suppliers report vision-guided orders now outpacing legacy unmarked orders across nearly every major pharmaceutical export account, a clear reversal from just a few years earlier. Manufacturers report this shift accelerating further next year. Linked demand sits in the Japan tablet market, projected by MMA to reach USD 84.4 billion by 2036 on a 4.5% CAGR.
Market Impact: Drives roughly 14% of demand








